Literature DB >> 25006730

Spironolactone for heart failure with preserved ejection fraction.

Henning Morawietz, Stefan R Bornstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25006730     DOI： 10.1056/NEJMc1405715

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Hufang Zhou; Wenhua Peng; Fuyao Li; Yuelin Wang; Baofu Wang; Yukun Ding; Qian Lin; Ying Zhao; Guozhong Pan; Xian Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-04

Review 2.  Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?

Authors:  Sumeet S Mitter; Sanjiv J Shah
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

3.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2021-05-22

Review 4.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; James Thomas; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28

5.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

6.  Sex differences in left ventricular afterload and diastolic function are independent from the aortic size.

Authors:  Hidemi Sorimachi; Koji Kurosawa; Kuniko Yoshida; Masaru Obokata; Takashi Noguchi; Minoru Naka; Shoichi Tange; Masahiko Kurabayashi; Kazuaki Negishi
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

7.  Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.

Authors:  Edmund Ym Chung; Marinella Ruospo; Patrizia Natale; Davide Bolignano; Sankar D Navaneethan; Suetonia C Palmer; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2020-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.